Skinderma PDRN + HA 2% Combo
Skinderma PDRN + HA 2% Combo. This is an advanced professional treatment designed for deep skin restoration, intensive hydration, and cellular regeneration.
The product is specifically developed for clinical use and is applied exclusively under specialist supervision, ensuring safety, predictability, and long-lasting results.
PDRN + HA 2% Combo is a combined formulation that brings together two key active components. It contains PDRN (polydeoxyribonucleotides), known for their ability to stimulate cellular regeneration, and hyaluronic acid at a 2% concentration, providing deep and prolonged hydration.
This formula works at the cellular level to restore skin structure, improve density, and enhance overall skin quality. It is particularly valuable in regenerative and anti-aging protocols.
The treatment activates skin renewal and regeneration processes, supports the repair of damaged tissues, deeply hydrates the skin, increases elasticity and firmness, and improves skin texture and tone. It gently stimulates the skin’s natural recovery mechanisms without disrupting the protective barrier.
Skinderma PDRN + HA 2% Combo is recommended for:
dry and dehydrated skin
loss of firmness and tone
age-related skin changes
dull complexion
skin after aggressive procedures (lasers, chemical peels)
the need for accelerated regeneration
The procedure is suitable for the face, neck, and décolleté as prescribed by a physician.
The procedure begins with a dermatologist consultation and professional skin assessment. After skin preparation, Skinderma PDRN + HA 2% Combo is applied, followed by post-procedure care and personalized recommendations. The treatment course is selected individually and typically consists of 4–6 sessions.
After completing the course, patients report deep and long-lasting hydration, improved skin density and smoothness, increased elasticity, faster skin recovery, and a fresher, well-groomed appearance. The effect is cumulative and becomes more pronounced after completing the full course.